Research Article
Volume 7 Issue 10 - 2020
Fournier’s Disease. A New Treatment
Morelos Adolfo García Sánchez1*, Mireya De La Fuente González2, Oswaldo Díaz González3, Elizabeth Mendoza Portillo4, Luis Andres Saenz Romero5, Fausto Romero Vallejo6, Alejandro Badillo Bravo7, María Isabel Estrada Rodríguez8, Jesús Alan Ureña Álvarez9, Arturo Reyes Martínez10, José Juan Lozano Nuevo11, Eduardo Hermes Cisneros Nava5 and César Hernández Martínez5
1Colonic and Rectal Surgeon and General Surgeon, Surgical Department at “Dr. Rubén Leñero” General Hospital Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, Mexico
2General Surgeon, Surgical Department at “Dr. Gaudencio Gonzalez Garza” General Hospital Specialized Medical Unit, “La Raza”, National Medical Center, Mexican Social Security Institute, National Autonomous University of Mexico, México City, México
2General Surgeon, Surgical Department at “Dr. Gaudencio Gonzalez Garza” General Hospital Specialized Medical Unit, “La Raza”, National Medical Center, Mexican Social Security Institute, National Autonomous University of Mexico, México City, México
3Internal Medicine and Rheumatologist, Department Internal Medicine at Hospital National Medical Center “20 de November ISSSTE”, National Autonomous University of Mexico, México City, México
4Internal Medicine and Critical Medicine Care, Intensive Care Unit Department at “Dr. Rubén Leñero” General Hospital Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, Mexico
55General Surgeon, Surgic Department at “Dr. Ruben Lener" and General Hospital, Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, Mexico
6General Surgeon and Gastrointestinal Endoscopy, Endoscopy Department at ABC Medical Center, National Autonomous University of Mexico, México City, Mexico
7General Surgeon, Surgical Department at “Dr. Belisario Dominguez” Specialty Hospital, Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, México
8General Surgeon, Surgical Department at “Dr. Gaudencio Gonzalez Garza” General Hospital Specialized Medical Unit, “La Raza”, National Medical Center, Mexican Social Security Institute, National Autonomous University of Mexico, México City, México
9General Surgeon and Gastrointestinal Endoscopy, Surgical Department at “Cristus Muguerza” Hospital, National Autonomous University of Mexico, Reynosa City Tamaulipas State, México
10Orthopedic and Traumatology, Traumatology Department at “Juárez de México” Hospital, Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, México
11Internal Medicine, Internal Medicine Department at “Ticoman” General Hospital Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, México
*Corresponding Author: Morelos Adolfo García Sánchez, Colonic and Rectal Surgeon and General Surgeon, Surgical Department at “Dr. Rubén Leñero” General Hospital Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, Mexico.
Received: August 26, 2020; Published: September 24, 2020


Background: Fournier's gangrene is a pathology with a high fatality rate, of unknown etiology and with a very unpredictable prognosis. Described by Jean Alfred Fournier in 1883. The term “Necrotizing Fasciitis” was introduced by Wilson in 1952. It is defined as a soft tissue infection that involves the muscular fasciae of the genital, anal and perineal areas, with a natural evolution that is rapidly progressive and deadly.

Objective: Describe the experience that has been evolutionary in the treatment paradigm for Fournier's disease. Analyze deductively and critically about the myths of Fournier's disease.

Method: It is a study with a retrospective, longitudinal, observational, descriptive and comparative design; using descriptive biostatistics procedures. The records of all patients treated surgically for Fournier's disease in the Surgery and/or Colon and Rectum departments of six second and third level health hospitals in Mexico City and the State of Mexico were reviewed.

Results: A total of 214 patients were analyzed, of which 188 were male (88%) and 26 were female (12%). With an age range of 16 to 79 years, average of 46 years and a bimodal mode of 44 and 38 years.

Discussion: Fournier's disease is a pathology that has undergone diagnostic-therapeutic changes over the years, with the intention of improving, of being competent; The various treatment modalities have had very mixed results; Therefore, the search for a conduct that regulates in a standardized, ethical, scientific, efficient, practical way, with low costs and that is based on scientific evidence, must be continued.

Conclusion: The speed with which the surgical intervention is carried out is essential; therapeutic delay deteriorates the prognosis of the patient, wide and aggressive debridement is essential in the first surgical procedure.


Keywords: Fournier; Fasciitis Necrotizing; Debridement Therapeutics; Forecast; Surgical


  1. Medina PJ., et al. “Historical review of Fournier's gangrene: Baurienne, 1764 and herod the great, 4 B.C”. European Urology4 (2009): 121.
  2. Oguz A., et al. “Fournier´s gangrene: A summary of 10 years of clinical experience”. International Surgery 5 (2015): 934-391.
  3. Wilson B. “Necrotizing fasciitis”. The American Journal of Surgery 4 (1952): 416-431.
  4. Stephens BJ. “Fournier´s gangrene: Historic (1764-1978) versus contemporary (1979-1978) differences in etiology and clinical importance”. The American Journal of Surgery 59 (1993): 149-154.
  5. Chernyadyev SA., et al. “Fournier´s gangrene: Literature review and clinical cases”. Urología Internationalis 1 (2018): 91-97.
  6. Chang FS., et al. “Suture technique to prevent air leakage during negative-pressure wound therapy in Fournier gangrene”. Plastic and Reconstructive Surgery 6 (2018): 1650.
  7. Insua-Pereira I., et al. “Fournier's gangrene: a review of reconstructive options”. Central European Journal of Urology 73 (2020): 74-79.
  8. Latarjet M and Ruiz-Liard A. “Anatomía Humana. Tomo I. 4th Editorial Médica Panamericana 2006”. Buenos Aires Argentina (2006).
  9. Doluoglu OG., et al. “Overview of different scoring systems in Fournier´s gangrene and assessment of prognostic factors”. Turkish Journal of Urology 42 (2016): 190-196.
  10. AlShehri YA., et al. “Management of Fournier´s gangrene with skin grafting by bagging technique of testes: case report”. GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW (2019).
  11. Singh A., et al. “Fournier´s gangrene. A clinical review”. Archivio Italiano Di Urologia E Andrologia3 (2016).
  12. Tang LM., et al. “The evaluation of microbiology and prognosis of Fournier´s gangrene in past five years”. Springer Plus14 (2015).
  13. Selahattin M., et al. “Fournier´s gangrene: Review of 36 cases”. Ulus Travma Acil Cerrahi Derg 5 (2019): 479-482.
  14. Egas-Ortega W and Y Cols. “Características de los casos de gangrena de Fournier atendidos en el Hospital Luis Vernaza de Guayaquil-Ecuador”. Revista Médica Vozandes 28 (2017): 27-32.
  15. Ballard DH., et al. “Preoperative CT findings and interobserver reliability of Fournier gangrene”. American Journal of Roentgenology 5 (2018): 1051-1057.
  16. Diario Oficial de la Federación. Costos Unitarios por Nivel de Atención Médica actualización al año (2020).
  17. Regalado-Altamirano JC. “Factores de riesgos asociados a gangrena de Fournier”. Revista de la Facultad de Medicina Humana 18 (2018): 92-100.
  18. Tarchouli M., et al. “Analysis of prognostic factors affecting mortality in Fournier´s gangrene: A study of 72 cases”. Canadian Urological Association Journal 9 (2015): 11-12.
  19. Sparenborg JD., et al. “Fournier´s gangrene: a modern analysis of predictors of outcomes”. Translational Andrology and Urology 4 (2019): 374-378.
  20. Chennamsetty A., et al. “Contemporary diagnosis and management of Fournier´s gangrene”. Therapeutic Advances in Urology4 (2015): 203-215.
  21. Camargo L and García-Perdomo HA. “Gangrena de Fournier: revisión de factores determinantes de mortalidad”. Revista Chilena de Cirugía3 (2016): 273-277.
  22. Wang C., et al. “Effectiveness of honey dressing in the treatment of diabetic foot ulcers: A systematic review and meta-analysis”. Complementary Therapies in Clinical Practice 34 (2019): 123-113.
  23. Urdaneta-Carruyo E., et al. “Gangrena de Fournier. Perspectivas actuales”. Anales de Medicina Interna 24 (2007): 190-194.
  24. Castellanos–Ramirez D.K., et al. “Manejo de Heridas”. Cirujano General 3 (2014): 112-120.
  25. Lacruz-Pérez B and Y Cols. “Abordaje posquirúrgico de un caso de gangrena de Fournier desde atención primaria”. Enferm Dermatol 37 (2019): 52-58.
  26. Brock WB., et al. “Temporary closure of open wounds: the vacuum pack”. The American Journal of Surgery 1 (1995): 30-34.
  27. Orhan E and Senen D. “Using negative pressure therapy for improving skin graft taking on genital area defects following Fournier gangrene”. Turkish Journal of Urology 43 (2017): 366-370.
  28. Lozano-Balderas G., et al. “Surgical Site Infection Rate Drops to 0% Using a Vacuum-Assisted Closure in Contaminated/Dirty Infected Laparotomy Wounds”. The American Journal of Surgery 5 (2017): 512-514.
  29. Sönmez MM., et al. “Comparison of two different vacuum-assisted closure (VAC) treatments of multiple chronic diabetic foot wounds in the same extremity”. Foot and Ankle Surgery 3 (2017): 173-178.
  30. Govea-Camacho LH., et al. “Impact of vacuum-assisted closure management in deep neck abscesses”. Cirugia y Cirujanos4 (2016): 275-281.
  31. Leclercq A., et al. “Skin graft secured by VAC (vacuum-assisted closure) therapy in chronic leg ulcers: A controlled randomized study”. Annales de Dermatologie et de Vénéréologie 1 (2016): 3-8.
  32. Janane A., et al. “Terapia de oxígeno hiperbárico complementaria al desbridamiento en el control de la gangrena de Fournier: utilidad de la puntuación de un índice de severidad en la predicción de la gravedad de la enfermedad y la supervivencia del paciente”. Actas Urológicas Españolas 6 (2011): 332-338.
  33. Valaguez-Velásquez C., et al. “Gangrena de Fournier en el Hospital de Infectologíadel Centro Médico Nacional “La Raza”análisis de 2 años”. Educación e Investigación Clínica1 (2001): 18-25.
  34. Bigliardi PL., et al. “Povidone iodine in wound healing: A review of current concepts and practices”. International Journal Surgery 4 (2017): 260-268.
  35. Touzel RE., et al. “Establishment of multi-species biofilm model to evaluate chlorhexidine efficacy”. Journal of Hospital Infection (2016): 154-160.
  36. Vojtěch P., et al. “Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents”. PLos one 14 (2019): 10-31.
  37. Assadian O., et al. “Use of wet-to-moist cleansing with different irrigation solutions to reduce bacterial bioburden in chronic wounds”. Journal of Wound 17 (2018): 10-16.
  38. García-Sánchez MA and Y Santillán-Arellano EG. “Enfermedad de Verneuil. Presentación de un caso y revisión de la literature”. Revista de Gastroenterología de México3 (2015): 225-227.
  39. García-Sánchez MA., et al. “Hemorrhoidal Thrombosis: Conservative Treatment”. Open Journal of Clinical and Medical Case Reports 4 (2017): 043.
  40. García-Sánchez MA and Y Cols. “Tratamiento quirúrgico de la fístula anorrectal compleja en herradura. Experiencia en el Servicio de Cirugía de Colon y Recto”. Revista Trauma en América Latina 1 (2012): 11-15.
  41. Jiménez-Bobadilla B y cols. “Utilidad de la colostomía en la gangrena de Fournier y su valor predictivo de mortalidad”. Cirujano General3 (2008): 141-148.
  42. Rodríguez-Wong U and Y Domínguez F. “Indicaciones en la gangrena de Fournier”. Revista del Hospital Juárez de México 3 (2004): 120-123.
  43. Medina-Polo J and Y Cols. “Gangrena de Fournier: estudio de los factores pronósticos en 90 pacientes”. Actas Urológicas Españolas 10 (2008): 1024-1030.
  44. Campos-Salcedo J and G Y Cols. “Reparación temprana de la lesión traumática de uretra posterior. Reporte de un caso y revisión de la literature”. Revista Mexicana de Urología 3 (2012): 113-118.
Citation: Morelos Adolfo García Sánchez., et al. “Fournier’s Disease. A New Treatment”. EC Gastroenterology and Digestive System 7.10 (2020): 69-86.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.